Human Papilloma Virus (HPV) Completed Phase 2 Trials for Bizalimogene ralaplasmid (DB16113)

Back to Human Papilloma Virus (HPV)

Also known as: Human Papilloma Virus / HPV Infections / HPV (Human Papillomavirus) / Human Papillomavirus (HPV) / HPV Infection / Human Papillomavirus / HPV Disease / Papilloma Virus, Human / Human Papillomavirus Infection / Human papillomavirus infection (disorder) / Human papilloma virus infection / Human Papillomavirus Viruses / Human papillomavirus (organism) / Papillomavirus Infections / Disease caused by Papillomavirus (disorder) / Papilloma viral infection / Papilloma viral infection NOS / Papilloma viral infections

Indication	Status	Phase
DBCOND0040889 (Human Papilloma Virus (HPV))	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03180684	Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)	Treatment	Bizalimogene ralaplasmid (DB16113) Imiquimod (DB00724)